Study
Integrated Genetic and Pharmacologic Interrogation of Rare Cancers
Study ID | Alternative Stable ID | Type |
---|---|---|
phs001121 | Cohort |
Study Description
Due to the paucity of patient derived models in rare cancers, identification of therapeutic targets remains challenging. We developed a patient derived model, CLF-PED-015-T, from a patient with an undifferentiated sarcoma. From this model, we performed pooled RNAi and CRISPR-Cas9 negative selection screens and integrated that with a small molecule screen. Integration of these data identified CDK4 and XPO1 as potential therapeutic targets.
Archive | Link Archive Accession |
---|---|
dbGaP | phs001121 |
Who archives the data?
